Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2005
08/24/2005CN1657066A Hard capsule for treating vascular headache
08/24/2005CN1657065A Soft capsule for treating vascular headaehe
08/24/2005CN1216056C Sulfamato hydroxamic acid metalloprotease inhibitor
08/24/2005CN1216055C Paroxetine hydrochloride anhydrous compound and its preparation method and use
08/24/2005CN1216054C 1,4-dihydro pyridine-3,5-carboxylic-acid derivatives and preparation method thereof
08/24/2005CN1216052C Anti-neurodegeneratively active 10-aminoaliphatyl-dibenz (b,f) oxepines
08/24/2005CN1216046C Improved methods of synthesis for 9-substituted hypoxanthine derivatives
08/24/2005CN1216038C Novel dicarboxylic acid derivatives
08/24/2005CN1216018C Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use
08/24/2005CN1215868C Medicine for treating diabetes peripheral nerve affection and preparation method thereof
08/24/2005CN1215842C Use of atropin in preparation of drug-relief medicine
08/23/2005US6933422 Nav2 channel gene-deficient mice
08/23/2005US6933387 Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles
08/23/2005US6933314 Integrin receptor inhibitors
08/23/2005US6933313 Carbazoles with hydroxyfunctional amide (hydroxamic or esters) are for inhibiting sPLA2 mediated release of fatty acids for treatment of conditions such as septic shock
08/23/2005US6933308 Aminoalkyl thiazole derivatives as KCNQ modulators
08/23/2005US6933306 Anticancer agents; antiinflammatory agents; autoimmune disease
08/23/2005US6933305 Amide compounds and use thereof
08/23/2005US6933303 Antidiabetic agents
08/23/2005US6933297 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione and the use thereof for the treatment of pain
08/23/2005US6933296 A 2H-pyridazine-1-one derivatives as bronchodilator agents for the treatment of asthma, chronic obstructive pulmonary disease, respiratory system disorders
08/23/2005US6933295 Substituted isoindoles and the use thereof
08/23/2005US6933293 Unit treatment dose and patient package
08/23/2005US6933282 increasing the effective amount of tyrosine hydroxylase (TH) in the central nervous systems (CNS) for the purpose of increasing TH-mediated dopamine production in the treatment of Parkinson's disease
08/23/2005US6933279 Peptides comprising a class A amphipathic helix when formulated with "D" amino acid residue(s) and/or having protected amino and carboxyl termini
08/23/2005US6933277 Administering polypeptide mixture
08/23/2005US6933147 Human cyclic nucleotide-gated channel polypeptide
08/23/2005US6933119 Methods and compositions for the detection and treatment of multiple sclerosis
08/23/2005US6933113 Modulation of endogenous gene expression in cells
08/23/2005US6932988 Comprises brewing black pekoe tea, then adding aspirin tablets, apple cider vinegar, and honey
08/23/2005US6932969 Ig fractions having immunomodulatory activity
08/23/2005CA2137668C Benzodiazepines and compositions for treating anxiety and panic disorders, and idiopathic and psychomotor epilepsy
08/23/2005CA2119782C Carbamate analogs of thiaphysovenine, pharmaceutical compositions, and method for inhibiting cholinesterases
08/19/2005WO2004069263A1 Analgesic composition
08/19/2005CA2513932A1 Analgesic composition
08/18/2005WO2005074988A1 Nerve cell differentiation inducer
08/18/2005WO2005074968A2 Medical use of basic peptides
08/18/2005WO2005074909A1 Combination drug
08/18/2005WO2005074907A1 Gene expression controlling agent
08/18/2005WO2003004608A3 Drug metabolizing enzymes
08/18/2005US20050182276 Process for the synthesis and crystalline form of agomelatine
08/18/2005US20050182258 Morphinan derivatives the quaternary ammonium salts thereof substituted in position 14, method for production and use thereof
08/18/2005US20050182244 Modified polypeptides stabilized in a desired conformation and methods for producing same
08/18/2005US20050182141 drug abuse, drug addiction; reduce cravings for food or addictive substance such as cocaine, amphetamine, nicotine, opiates, tobacco, alcohol or ecstasy; ketone or hydroxy aryl-cycloalkyl sulfides or S-oxides thereof e.g. 1-(1-(3,4-dichlorophenyl)cyclobutyl)-2-(2-(dimethylamino)ethylthio)ethanone
08/18/2005US20050182135 Enhancement of alcohol metabolism
08/18/2005US20050182130 Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
08/18/2005US20050182126 2-Thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
08/18/2005US20050182111 Alkenyl-substituted spirocyclic sulfamides as inhibitors of gamma-secretase
08/18/2005US20050182109 Heteroaryl substituted spriocyclic sulfamides for inhibition of gamma secretase
08/18/2005US20050182104 E.g., Methyl 2-[2-[2-(3,5-difluorophenyl)acetyl-amino]propanoylamino]-5-propylthiazole-4-carboxylate; beta -amyloid peptide inhibitors; used to treat senile dementia, Alzheimer's disease, Down's syndrome, Parkinson's disease, amyloid angiopathy and/or cerebrovascular disorders
08/18/2005US20050182103 Substituted 2,3-diphenyl pyridines
08/18/2005US20050182100 Method of use
08/18/2005US20050182094 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of respiratory system disorders or as antiallergens
08/18/2005US20050182093 Novel compounds
08/18/2005US20050182070 Method for the treatment of allergic conditions
08/18/2005US20050182069 For treatment of asthma, allergies, inflammation and anxiety; antihistamines; sedatives; tranquilizing agents; 2[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetamide
08/18/2005US20050182068 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
08/18/2005US20050182057 Aryl N-cyanoguanidines and methods related thereto
08/18/2005US20050182050 Therapeutic heterocyclic compounds
08/18/2005US20050182047 Treatment of demyelinating disorders
08/18/2005US20050182046 Alzheimer's disease; 3-(S)-(N'-(3,5-difluorophenylacetyl)-L-alaninyl)amino-1-benzyl- epsilon -caprolactam; 4-(N'-(3,5-Difluorophenylacetyl)-L-alaninyl)amino-1-(pyrid-4-yl)-71,2,3,4-tetrahydroisoquinolin-3-one
08/18/2005US20050182045 Fused ring 4-oxopyrimidine derivative
08/18/2005US20050182044 donepezil, rivastigmine, metrifonate, physostigmine, eptastigmine, galantamine, and huperzine A with beta-amyloid peptide inhibitor phenserine, tolserine, N1-benzylnorphysostigmine, N1-benzylnorphenserine, N1benzylnortolserine, N1-benzylnorcymserine, Alzheimer's disease
08/18/2005US20050182042 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
08/18/2005US20050182035 cyclohexane ring is 3,5-dihydroxy-substituted and 2,4-alkylene-bridged; treating metabolic bone disease, cancer, skin disorders, immune system disorders, asthma, hypertension, hypothyroidism, hypocalcemia, female infertility and alopecia
08/18/2005US20050182034 Method of locking 1alpha-OH of vitamin D compounds in axial orientation
08/18/2005US20050181998 Prion inhibiting peptides and derivatives thereof
08/18/2005US20050181991 Use of artemin, a member of the GDNF ligand family
08/18/2005US20050181980 Administering a formulation comprising an effective amount of:a sulfonylurea receptor 1 (SUR1) antagonist that reduces the activity of a NCCa-ATP channel; a pharmaceutically acceptable carrier
08/18/2005US20050181507 Gene delivery vectors with cell type specificity for mesenchymal stem cells
08/18/2005US20050181414 Peptides associated with serine protease active site for use in identification of modulators for treatment of cell proliferative disorders
08/18/2005US20050181391 Method of detecting and treating tuberous sclerosis complex associated disorders
08/18/2005US20050181054 comprising a water-insoluble and/or water-low soluble substance, a medicament, and an aqueous medium, and having an osmotic pressure of less than 290 mOsm; efficient penetration and high permeability blood at the mucosa
08/18/2005US20050181046 Tamper-resistant oral opioid agonist formulations
08/18/2005US20050180955 gene therapy; delivering recombinant adeno-associated virus virions to the brain; pumping; transgene encodes an aromatic amino acid decarboxylase
08/18/2005US20050180947 Novel application of vaccination against TNF-alpha
08/18/2005DE102004004787A1 New effector-linker and effector-recognition unit conjugates derived from epothilones, useful as targeted drugs for treating proliferative diseases, e.g. tumors or neurodegenerative disease
08/18/2005DE102004003801A1 Recovering melanin from plant materials, for use e.g. in cancer treatment or as semiconductor, by extracting with sodium hydroxide solution, acidifying extract and purifying precipitate
08/18/2005DE102004002885A1 New pyrrole alkaloid daminin and its derivatives, are intracellular calcium ion concentration reducing neuroprotective agents useful for treating neurodegenerative diseases, e.g. Alzheimer's disease
08/18/2005DE102004002884A1 New aspernigrin B derivatives are intracellular calcium ion concentration reducing neuroprotective agents, useful for treating neurodegenerative diseases e.g. Parkinson's disease and multiple sclerosis
08/18/2005CA2556161A1 Heparan-sulfate proteoglycan degrading enzymes for promotion of nerve regeneration
08/18/2005CA2555491A1 Pyrroloquinoline and piperidoquinoline derivatives, preparation thereof, compositions containing them and uses thereof
08/18/2005CA2555463A1 Inhibitors of tgf-r signaling for treatment of cns disorders
08/18/2005CA2555316A1 Combined pharmaceutical composition
08/18/2005CA2555311A1 Diazabicyclic aryl derivatives as nicotinic acetylcholine receptor ligands
08/18/2005CA2555262A1 1h-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors
08/18/2005CA2555018A1 Treatment of conditions involving dopaminergic neuronal degeneration using nogo receptor antagonists
08/18/2005CA2554809A1 Novel n-alkyl thiourea-and thioamide-substituted imidazolyl inhibitors and glutaminyl cyclase
08/18/2005CA2554761A1 Neuroprotective dietary supplement
08/18/2005CA2554760A1 Use of a complex of ginkgo flavonoids and phosphatidylserine for enhanced cognitive function
08/18/2005CA2554082A1 Use of epothilones in the treatment of neuronal connectivity defects such as schizophrenia and autism
08/18/2005CA2554050A1 Diazabicyclic aryl derivatives as cholinergic receptor modulators
08/18/2005CA2552940A1 1,3,5-trisubstituted 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
08/17/2005EP1564293A1 Neural thread protein gene expression and detection of Alzheimer's disease
08/17/2005EP1564219A1 N-terminally monopegylated polypeptides and process for their preparation
08/17/2005EP1564202A1 Novel process for synthesizing and a novel crystal form of agomelatin as well as pharmaceutical preparations containing these
08/17/2005EP1563852A1 Compounds which can be used to diagnose and monitor diseases associated with the formation of amyloid protein fibrils
08/17/2005EP1563843A1 Botulinum toxins for treating various disorders and associated pain
08/17/2005EP1563839A1 A method of analgesia
08/17/2005EP1563059A1 Methods, nucleic acid constructs and cells for treating neurodegenerative disorders
1 ... 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 ... 1833